Last updated: 2026-09-16 09:46:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
InMode Ltd. (INMD) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $14.78, with a market capitalisation of $856.83M and a P/E ratio of 14.47. Over the past 52 weeks, its price has ranged from $12.72 to $16.74. This page covers its latest market performance, valuation, price trends and company information.
$856.83M | |
$14.79 | |
$99.27 | |
$2.15 | |
$14.87 | |
1.79K | |
613.62K | |
14.47 | |
$16.74 | |
$12.72 | |
-- | |
-- |
InMode Ltd. (INMD) is trading at $14.78 in pre-market trading as of 2026-09-16 09:19:00, down 0.60% ($0.09) from the previous close of $14.87
Pre-market trading shows how investors are pricing INMD before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, InMode Ltd. (INMD) moved from $14.91 to $14.78, representing a decline of 0.87% ($0.13).
The stock traded between $14.60 and $14.97 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 543.79 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 51.3%
INMD is currently trading at $14.78, placing it 51.3% of the way from its 52-week low of $12.72 to its 52-week high of $16.74. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
| Employees | 660 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of InMode Ltd. (INMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.